Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
-12.58%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$43.6B
AUM Growth
+$43.6B
(-17%)
Cap. Flow
-$397M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,191
New
111
Increased
279
Reduced
407
Closed
116
Top Buys
| 1 |
Amazon
AMZN
|
$919M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$415M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
$130M |
| 4 |
Textron
TXT
|
$95.7M |
| 5 |
Sanofi
SNY
|
$90.9M |
Top Sells
| 1 |
Royalty Pharma
RPRX
|
$342M |
| 2 |
Exxon Mobil
XOM
|
$230M |
| 3 |
Dollar Tree
DLTR
|
$228M |
| 4 |
Nutrien
NTR
|
$213M |
| 5 |
National Vision
EYE
|
$198M |
Sector Composition
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Caterpillar
CAT
$196B
| $61.2M | 0.14% |
342,417
-62,487
| -15% | -$11.2M |
|
152
Public Service Enterprise Group
PEG
$41.1B
| $60.7M | 0.14% |
959,984
-583,000
| -38% | -$36.9M |
|
153
Zoetis
ZTS
$69.3B
| $60.7M | 0.14% |
353,192
-140,832
| -29% | -$24.2M |
|
154
Parker-Hannifin
PH
$96.2B
| $59M | 0.14% |
239,934
+16,500
| +7% | +$4.06M |
|
|
SBNY
155
DELISTED
Signature Bank
SBNY
| $58.7M | 0.13% |
327,762
+152,107
| +87% | +$27.3M |
|
156
Ametek
AME
$42.7B
| $58.7M | 0.13% |
534,117
-63,511
| -11% | -$6.98M |
|
157
Dollar General
DG
$23.9B
| $58.5M | 0.13% |
+238,300
| New | +$58.5M |
|
158
Fidelity National Information Services
FIS
$36.5B
| $58.3M | 0.13% |
636,078
+20,200
| +3% | +$1.85M |
|
159
Schlumberger
SLB
$55B
| $58M | 0.13% |
1,620,967
-3,400
| -0.2% | -$122K |
|
160
FedEx
FDX
$54.5B
| $57.4M | 0.13% |
253,304
-1,200
| -0.5% | -$272K |
|
161
Warner Bros
WBD
$28.8B
| $57.4M | 0.13% |
+4,278,148
| New | +$57.4M |
|
|
ITCI
162
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $57.3M | 0.13% |
1,003,271
+153,271
| +18% | +$8.75M |
|
163
Emerson Electric
EMR
$74.3B
| $57.2M | 0.13% |
719,236
-957,630
| -57% | -$76.2M |
|
164
Edwards Lifesciences
EW
$47.8B
| $56.8M | 0.13% |
597,566
-54,400
| -8% | -$5.17M |
|
165
Charter Communications
CHTR
$36.3B
| $56.5M | 0.13% |
120,647
-3,800
| -3% | -$1.78M |
|
166
EOG Resources
EOG
$68.2B
| $56.4M | 0.13% |
+510,700
| New | +$56.4M |
|
167
Becton Dickinson
BDX
$55.3B
| $55.9M | 0.13% |
226,915
-10,500
| -4% | -$2.59M |
|
168
Novo Nordisk
NVO
$251B
| $55.6M | 0.13% |
498,805
-60,195
| -11% | -$6.71M |
|
169
Air Products & Chemicals
APD
$65.5B
| $55.5M | 0.13% |
230,940
-50,600
| -18% | -$12.2M |
|
170
Constellation Brands
STZ
$28.5B
| $55.5M | 0.13% |
238,067
+66,500
| +39% | +$15.5M |
|
171
Cenovus Energy
CVE
$29.9B
| $55.1M | 0.13% |
2,900,000
-950,000
| -25% | -$18.1M |
|
172
Incyte
INCY
$16.5B
| $54.8M | 0.13% |
721,109
-871,700
| -55% | -$66.2M |
|
173
Intercontinental Exchange
ICE
$101B
| $54.7M | 0.13% |
581,390
-5,300
| -0.9% | -$498K |
|
|
PNTM
174
DELISTED
Pontem Corporation
PNTM
| $53.2M | 0.12% |
5,400,000
| – | – |
|
175
Stryker
SYK
$150B
| $52.8M | 0.12% |
265,499
-100
| -0% | -$19.9K |
|